上海谊众(688091.SH)发布半年度业绩，归母净利润3800万元，同比增长10.13%

Core Insights - Shanghai Yizhong (688091.SH) reported a revenue of 160 million yuan for the first half of 2025, representing a year-on-year growth of 31.48% [1] - The net profit attributable to shareholders reached 38 million yuan, an increase of 10.13% compared to the previous year [1] - The company's non-recurring net profit was 37.06 million yuan, reflecting a year-on-year growth of 11.74% [1] - Basic earnings per share stood at 0.18 yuan [1] Revenue Growth - The significant revenue growth of 31.48% was primarily driven by the inclusion of the core product, paclitaxel micelles, in the national medical insurance catalog [1] - Sales volume of paclitaxel micelles saw a remarkable increase of 487% compared to the same period last year [1]